Table 3 The relative risk for PPCs in patients with esophageal cancer who underwent esophagectomy by the quintiles of FEV1%pred and DLco %pred.
FEV1%pred | P for trend | |||||
|---|---|---|---|---|---|---|
Quintile 1 (n = 165) ≤ 78 | Quintile 2 (n = 165) > 78– ≤ 87 | Quintile 3 (n = 171) > 87– ≤ 94 | Quintile 4 (n = 155) > 94– ≤ 103 | Quintile 5 (n = 154) > 103– ≤ 139 | ||
Crude | 2.41 (1.49–3.90) | 1.87 (1.13–3.09) | 1.47 (0.87–2.49) | 1.15 (0.65–2.04) | Reference | < 0.01 |
Adjusteda | 2.05 (1.24–3.38) | 1.69 (1.02–2.82) | 1.55 (0.92–2.62) | 1.17 (0.66–2.06) | Reference | < 0.01 |
IPTW | 2.72 (1.60–4.64) | 1.98 (1.12–3.48) | 1.66 (0.93–2.97) | 1.30 (0.70–2.42) | Reference | < 0.01 |
DLco %pred | P for trend | |||||
|---|---|---|---|---|---|---|
Quintile 1 (n = 166) ≤ 72 | Quintile 2 (n = 171) > 72– ≤ 83 | Quintile 3 (n = 160) > 83– ≤ 92 | Quintile 4 (n = 153) > 92– ≤ 102 | Quintile 5 (n = 160) > 102– ≤ 148 | ||
Crude | 3.35 (2.04–5.48) | 1.98 (1.16–3.38) | 1.59 (0.90–2.80) | 1.23 (0.67–2.26) | Reference | < 0.01 |
Adjusteda | 2.98 (1.72–5.15) | 1.88 (1.08–3.26) | 1.59 (0.89–2.82) | 1.24 (0.68–2.28) | Reference | < 0.01 |
IPTW | 2.83 (1.63–4.92) | 1.83 (1.01–3.30) | 1.57 (0.84–2.93) | 0.90 (0.45–1.79) | Reference | < 0.01 |